By vgreene, 8 January, 2018 Drug- and pt-specific factors to consider when selecting antihyperglycemic tx
By vgreene, 8 January, 2018 Drug- and pt-specific factors to consider when selecting antihyperglycemic tx
By vgreene, 8 January, 2018 Then, if A1C not controlled, proceed to 1 of 3 options: 1) Add 1 rapid-acting insulin injection before largest meal; 2) Add GLP-1 RA; or 3) Change to premixed insulin bid (before breakfast and supper)
By vgreene, 8 January, 2018 Continuously re-eval med regimen and adjust prn to account for pt factors and regimen complexity [E]
By vgreene, 8 January, 2018 If established ASCVD and cardiac-protective drug not already part of regimen, add agent w/ proven cardiac benefits (presently empagliflozin and liraglutide) after considering drug-specific and pt factors [A]; canagliflozin may also be considered to ↓ CV e
By vgreene, 8 January, 2018 Continuously re-eval med regimen and adjust prn to account for pt factors and regimen complexity [E]
